Can Axillary Dissection be Avoided by Improved Molecular Biological Diagnosis?
Thomas Lindahl(Uppsala University Hospital), Jonas Bergh(Karolinska Institutet), Georg Engel(Sophiahemmet Hospital), Henrik Lindman(Uppsala University), Sigrid Klaar(Uppsala University Hospital), Judith Bjöhle(Karolinska University Hospital), Johan Ahlgren(Gävle Hospital), J. Andersson(Sophiahemmet Hospital), E. von Schoultz(Sophiahemmet Hospital)
Cited by 17
Related Papers
Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis
|The Lancet|2014|4.7k
Pembrolizumab for Early Triple-Negative Breast Cancer
|New England Journal of Medicine|2020|3.1k
3rd ESO–ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC 3)
|Annals of Oncology|2016|2.1k